CraniUS LLC Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2021

Location

Baltimore MD US

Primary Industry

Medical Devices & Equipment

About

Based in Maryland, US, and founded in 2021 by CTO Deborah Weidman, and CMO Chad Gordon, CraniUS LLC, a.k.a. CraniUS operates as a developer of medical devices that could help patients with chronic diseases to passage medicine directly to the brain. In September 2022, CraniUS LLC raised USD 19.4 million in a Series A funding from individual investors. As of September 2022, Mike Maglin is the CEO of the company. The company provides a medical device powered by a novel wireless charging system, enabling chronic medicine delivery directly to the brain. CraniUS’s flagship product is being developed to bypass the challenges presented by the blood-brain barrier, which has rendered traditional treatments of brain disease ineffective. CraniUS plans to use its proceeds from September 2022 funding to drive the development of its flagship device, and support its FDA approval for a first-in-human clinical study.

Current Investors

State of Maryland

Request a demo to show more

Primary Industry

Medical Devices & Equipment

Sub Industries

Healthcare, Diagnostic Equipment, Surgical Devices

Website

www.craniusmed.com

Verticals

HealthTech, Manufacturing

Company Stage

Series A

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.